Biosion is a global biotech company focusing on the discovery and clinical development of innovative biologics to treat resistant, refractory, relapsed and residual immune and oncologic diseases for patients worldwide.
With its world-class visionary pharmaceutical advisory team and global biologics development team, Biosion is committed to creating and delivering the next generation of innovative therapeutics with significant medical outcomes for patients worldwide.
To deliver breakthrough therapeutics to patients globally
Biosion is a Leading “In Global For Global” Biotech Company
Biosion is developing breakthrough therapies for patients worldwide through our global team, intelligence, network and operations. We create innovative assets through our proprietary internal discovery engine while we also develop global complementary partnerships to create value for patients, employees, stakeholders and for communities worldwide.
“With our global professional team and operations, we are passionate to deliver breakthrough medicines for patients worldwide through the synergy of robust innovative discovery, cutting-edge technologies and global collaborations.”